Literature DB >> 23975838

The value of repeat biopsy in the management of lupus nephritis: an international multicentre study in a large cohort of patients.

Fabio Pagni1, Stefania Galimberti, Paolo Goffredo, Maria Basciu, Sara Malachina, Daniela Pilla, Eleonora Galbiati, Franco Ferrario.   

Abstract

BACKGROUND: The International Society of Nephrology/Renal Pathology Society (ISN/RPS) classification represents the gold standard for the histological evaluation of Systemic Lupus Erythematosus (SLE) nephritis. A repeat biopsy (RB) might be an important tool to provide information on long-term renal outcomes and optimal therapy. Aims of this study were to evaluate the use of the ISN/RPS classification and the role of RB in routine clinical practice.
METHODS: A total number of 142 patients with SLE nephritis and with adequate reference and RB samples were included in this multicentre retrospective study. A meticulous histological examination was centrally performed on first and RB and compared with clinical variables and follow-up data.
RESULTS: Morphological features of the ISN/RPS classification: at first and RB, significant differences were observed between segmental classes (III, IV-S) and Class IV-G in mesangial proliferation, wire loops and tuft necrosis. Clinical features and ISN/RPS classification: the correlation between serum creatinine, proteinuria, blood pressure levels and histological classes at first and RB demonstrated more severe renal disease in Class IV-G, both at first and RB. Agreement between ISN/RPS classification at first and RB: 40.8% of patients changed the histological class. Fifty per cent of Class II (mild mesangial form) were reclassified as Class IV-G at RB, whereas 18.9% of Class IV-G were reclassified as Class II. The transition among segmental (III/IV-S) and mesangial forms (II/IV-G) was extremely rare. The comparison between the clinical parameters at the final follow-up and the ISN/RPS classification confirmed that the trend of serum creatinine and proteinuria between the different classes was better described at the RB (higher in Class IV-G) than on the first biopsy.
CONCLUSIONS: The histopathological data suggest that morphological differences between segmental and global forms do exist, possibly due to different pathogenetic mechanisms. An RB strategy could provide additional information on long-term renal outcomes. A strategy of protocol biopsies could be useful in perspective future trials to better understand the therapeutic response and the natural history of this disease.

Entities:  

Keywords:  SLE nephritis; repeat biopsy

Mesh:

Year:  2013        PMID: 23975838     DOI: 10.1093/ndt/gft272

Source DB:  PubMed          Journal:  Nephrol Dial Transplant        ISSN: 0931-0509            Impact factor:   5.992


  11 in total

1.  Revised ISN/RPS 2018 classification of lupus renal pathology predict clinical remission.

Authors:  Kornwipa Krassanairawiwong; Mongkon Charoenpitakchai; Ouppatham Supasyndh; Bancha Satirapoj
Journal:  Int Urol Nephrol       Date:  2021-03-08       Impact factor: 2.370

2.  Understanding Histolopathologic Characteristics to Predict Renal Outcomes in Lupus Nephritis.

Authors:  Vladimir Tesar; Zdenka Hruskova
Journal:  Clin J Am Soc Nephrol       Date:  2017-05-04       Impact factor: 8.237

Review 3.  A Histology-Guided Approach to the Management of Patients with Lupus Nephritis: Are We There Yet?

Authors:  Bogdan Obrișcă; Alexandra Vornicu; Alexandru Procop; Vlad Herlea; George Terinte-Balcan; Mihaela Gherghiceanu; Gener Ismail
Journal:  Biomedicines       Date:  2022-06-15

4.  Expert Perspective: An Approach to Refractory Lupus Nephritis.

Authors:  Swati Arora; Brad H Rovin
Journal:  Arthritis Rheumatol       Date:  2022-04-25       Impact factor: 15.483

5.  History of proliferative glomerulonephritis predicts end stage kidney disease in pure membranous lupus nephritis.

Authors:  Andrea Fava; Paride Fenaroli; Avi Rosenberg; Serena Bagnasco; Jessica Li; Jose Monroy-Trujillo; Derek Fine; Mohamed G Atta; Michelle Petri
Journal:  Rheumatology (Oxford)       Date:  2022-05-30       Impact factor: 7.046

Review 6.  Update on Lupus Nephritis.

Authors:  Salem Almaani; Alexa Meara; Brad H Rovin
Journal:  Clin J Am Soc Nephrol       Date:  2016-11-07       Impact factor: 8.237

7.  New Insights Into an Overlooked Entity: Long-Term Outcomes of Membranous Lupus Nephritis From a Single Institution Inception Cohort.

Authors:  Eleni Kapsia; Smaragdi Marinaki; Ioannis Michelakis; George Liapis; Petros P Sfikakis; Maria G Tektonidou; John Boletis
Journal:  Front Med (Lausanne)       Date:  2022-04-14

8.  Interstitial inflammation and interstitial fibrosis and tubular atrophy predict renal survival in lupus nephritis.

Authors:  Parker C Wilson; Michael Kashgarian; Gilbert Moeckel
Journal:  Clin Kidney J       Date:  2017-08-31

Review 9.  The value of repeat biopsy in lupus nephritis flares.

Authors:  Javier Narváez; Milagros Ricse; Montserrat Gomà; Francesca Mitjavila; Xavier Fulladosa; Olga Capdevila; Joan Torras; Xavier Juanola; Ramón Pujol-Farriols; Joan Miquel Nolla
Journal:  Medicine (Baltimore)       Date:  2017-06       Impact factor: 1.817

10.  Rapid and Complete Remission of Class IV Lupus Nephritis with Massive Wire Loop Lesions.

Authors:  Tomo Suzuki; Ryutaro Matsumura; Hiroshi Kitamura; Yugo Shibagaki
Journal:  Case Rep Nephrol Dial       Date:  2018-03-22
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.